Antimicrobials and the risk of torsades de pointes: the contribution from data mining of the US FDA Adverse Event Reporting System (Q33542747)

27 July 2017

Antimicrobials and the risk of torsades de pointes: the contribution from data mining of the US FDA Adverse Event Reporting System (English)

1 reference

27 July 2017

1 reference

1 reference

3

Domenico Motola

1 reference

27 July 2017

Elisabetta Poluzzi

1

0 references

Emanuel Raschi

object named as

Emanuel Raschi

series ordinal

2

0 references

Fabrizio De Ponti

object named as

Fabrizio De Ponti

series ordinal

5

0 references

Ugo Moretti

series ordinal

4

object named as

Ugo Moretti

1 reference

27 July 2017

1 April 2010

1 reference

27 July 2017

1 reference

27 July 2017

33

1 reference

27 July 2017

4

1 reference

27 July 2017

303-314

1 reference

https://scigraph.springernature.com/pub.10.2165/11531850-000000000-00000

27 July 2017

0 references

cites work

Blockade of HERG channels by HIV protease inhibitors.

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11531850-000000000-00000

Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview

21 January 2018

1 reference

12 December 2020

Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non-case study in the French pharmacovigilance system database

1 reference

12 December 2020

Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin

1 reference

12 December 2020

Novel statistical tools for monitoring the safety of marketed drugs

1 reference

12 December 2020

Drug-induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS).

1 reference

12 December 2020

Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety bias

1 reference

12 December 2020

Antimicrobial-associated QT interval prolongation: pointes of interest

1 reference

12 December 2020

Time-to-signal comparison for drug safety data-mining algorithms vs. traditional signaling criteria

1 reference

12 December 2020

Stratification for spontaneous report databases

1 reference

12 December 2020

Effect of macrolide and fluoroquinolone antibacterials on the risk of ventricular arrhythmia and cardiac arrest: an observational study in Italy using case-control, case-crossover and case-time-control designs.

1 reference

12 December 2020

Quantitative signal detection using spontaneous ADR reporting

1 reference

12 December 2020

1 reference

12 December 2020

Data mining in pharmacovigilance: the need for a balanced perspective

1 reference

12 December 2020

QT prolongation through hERG K(+) channel blockade: current knowledge and strategies for the early prediction during drug development

1 reference

12 December 2020

Clinical evaluation of QT/QTc prolongation and proarrhythmic potential for nonantiarrhythmic drugs: the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use E14 guideline.

1 reference

12 December 2020

Effects of standard and supratherapeutic doses of nelfinavir on cardiac repolarization: a thorough QT study

1 reference

12 December 2020

Drug-induced prolongation of the QT interval

1 reference

12 December 2020

The hERG K+ channel: target and antitarget strategies in drug development

1 reference

12 December 2020

Perspectives on the use of data mining in pharmaco-vigilance

1 reference

12 December 2020

Torsade de pointes induced by systemic antifungal agents: lessons from a retrospective analysis of published case reports.

1 reference

12 December 2020

Data mining for signals in spontaneous reporting databases: proceed with caution

1 reference

12 December 2020

Application of quantitative signal detection in the Dutch spontaneous reporting system for adverse drug reactions

1 reference

12 December 2020

Anecdotes that provide definitive evidence

1 reference

12 December 2020

The role of data mining in pharmacovigilance

1 reference

12 December 2020

Role of antiretroviral treatment in prolonging QTc interval in HIV-positive patients

1 reference

12 December 2020

'Extreme duplication' in the US FDA Adverse Events Reporting System database

1 reference

12 December 2020

Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias.

1 reference

12 December 2020

A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions.

1 reference

12 December 2020

Introducing MEDWatch. A new approach to reporting medication and device adverse effects and product problems

1 reference

12 December 2020

Concomitant risk factors in reports of torsades de pointes associated with macrolide use: review of the United States Food and Drug Administration Adverse Event Reporting System

1 reference

12 December 2020

Torsades de pointes induced by antibiotics.

1 reference

12 December 2020

Impact of stratification on adverse drug reaction surveillance

1 reference

12 December 2020

Replication of the Weber effect using postmarketing adverse event reports voluntarily submitted to the United States Food and Drug Administration

1 reference

12 December 2020

Early postmarketing drug safety surveillance: data mining points to consider

1 reference

12 December 2020

Drug-versus-drug adverse event rate comparisons: a pilot study based on data from the US FDA Adverse Event Reporting System

1 reference

12 December 2020

Decision support methods for the detection of adverse events in post-marketing data

1 reference

12 December 2020

Torsades de pointes associated with fluoroquinolones

1 reference

12 December 2020

QT prolongation with antimicrobial agents: understanding the significance

1 reference

12 December 2020

Gold standards in pharmacovigilance: the use of definitive anecdotal reports of adverse drug reactions as pure gold and high-grade ore

1 reference

12 December 2020

10.2165/11531850-000000000-00000

Identifiers

DOI

1 reference

PubMed ID

20297862

Dimensions Publication ID

27 July 2017

1020464561

0 references

Fatcat ID

release_bu6y6lymgfci7c3r5akjgkmtn4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bu6y6lymgfci7c3r5akjgkmtn4

24 November 2022

mapped directly with Wikidata item

PubMed ID

20297862

1 reference

PubMed ID

20297862